AAAAAA

   
Results: 1-12 |
Results: 12
CLINICAL COMPARISON OF TARDIVE AND IDIOPATHIC CERVICAL DYSTONIA
Authors: MOLHO ES FEUSTEL PJ FACTOR SA
Citation: Es. Molho et al., CLINICAL COMPARISON OF TARDIVE AND IDIOPATHIC CERVICAL DYSTONIA, Movement disorders, 13(3), 1998, pp. 486-489
ACUTE DELIRIUM AFTER WITHDRAWAL OF AMANTADINE IN PARKINSONS-DISEASE
Authors: FACTOR SA MOLHO ES BROWN DL
Citation: Sa. Factor et al., ACUTE DELIRIUM AFTER WITHDRAWAL OF AMANTADINE IN PARKINSONS-DISEASE, Neurology, 50(5), 1998, pp. 1456-1458
CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICOBASAL DEGENERATION
Authors: KOMPOLITI K GOETZ CG BOEVE BF MARAGANORE DM AHLSKOG JE MARSDEN CD BHATIA KP GREENE PE PRZEDBORSKI S SEAL EC BURNS RS HAUSER RA GAUGER LL FACTOR SA MOLHO ES RILEY DE
Citation: K. Kompoliti et al., CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICOBASAL DEGENERATION, Archives of neurology, 55(7), 1998, pp. 957-961
ADULT-ONSET TICS ASSOCIATED WITH PERIPHERAL INJURY
Authors: FACTOR SA MOLHO ES
Citation: Sa. Factor et Es. Molho, ADULT-ONSET TICS ASSOCIATED WITH PERIPHERAL INJURY, Movement disorders, 12(6), 1997, pp. 1052-1055
THE EFFECT OF DANCING ON DYSTONIA
Authors: MOLHO ES FACTOR SA PODSKALNY GD BROWN D
Citation: Es. Molho et al., THE EFFECT OF DANCING ON DYSTONIA, Movement disorders, 11(2), 1996, pp. 225-227
CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICO-BASAL GANGLIONIC DEGENERATION
Authors: KOMPOLITI K GOETZ C MARAGANORE DM BOEVE BF MARSDEN CD BHATIA KP GREENE PE PRZEDBORSKI S SEAL ECJ BURNS RS HAUSER RA GAUGER I FACTOR SA MOLHO ES RILEY DE
Citation: K. Kompoliti et al., CLINICAL PRESENTATION AND PHARMACOLOGICAL THERAPY IN CORTICO-BASAL GANGLIONIC DEGENERATION, Annals of neurology, 40(3), 1996, pp. 171-171
COMBINED CLOZAPINE AND ELECTROCONVULSIVE-THERAPY FOR THE TREATMENT OFDRUG-INDUCED PSYCHOSIS IN PARKINSONS-DISEASE
Authors: FACTOR SA MOLHO ES BROWN DL
Citation: Sa. Factor et al., COMBINED CLOZAPINE AND ELECTROCONVULSIVE-THERAPY FOR THE TREATMENT OFDRUG-INDUCED PSYCHOSIS IN PARKINSONS-DISEASE, The Journal of neuropsychiatry and clinical neurosciences, 7(3), 1995, pp. 304-307
THE USE OF PRAMIPEXOLE, A NOVEL DOPAMINE (DA) AGONIST, IN ADVANCED PARKINSONS-DISEASE
Authors: MOLHO ES FACTOR SA WEINER WJ SANCHEZRAMOS JR SINGER C SHULMAN L BROWN D SHELDON C
Citation: Es. Molho et al., THE USE OF PRAMIPEXOLE, A NOVEL DOPAMINE (DA) AGONIST, IN ADVANCED PARKINSONS-DISEASE, Journal of neural transmission. Supplementum, (45), 1995, pp. 225-230
PSYCHOGENIC MOVEMENT-DISORDERS - FREQUENCY, CLINICAL PROFILE, AND CHARACTERISTICS
Authors: FACTOR SA PODSKALNY GD MOLHO ES
Citation: Sa. Factor et al., PSYCHOGENIC MOVEMENT-DISORDERS - FREQUENCY, CLINICAL PROFILE, AND CHARACTERISTICS, Journal of Neurology, Neurosurgery and Psychiatry, 59(4), 1995, pp. 406-412
CLOZAPINE - A 2-YEAR OPEN TRIAL IN PARKINSONS-DISEASE PATIENTS WITH PSYCHOSIS
Authors: FACTOR SA BROWN D MOLHO ES PODSKALNY GD
Citation: Sa. Factor et al., CLOZAPINE - A 2-YEAR OPEN TRIAL IN PARKINSONS-DISEASE PATIENTS WITH PSYCHOSIS, Neurology, 44(3), 1994, pp. 544-546
CLOZAPINE - A 2-YEAR OPEN TRIAL IN PARKINSONIAN-PATIENTS WITH PSYCHOSIS
Authors: FACTOR SA BROWN D MOLHO ES PODSKALNY GD
Citation: Sa. Factor et al., CLOZAPINE - A 2-YEAR OPEN TRIAL IN PARKINSONIAN-PATIENTS WITH PSYCHOSIS, Neurology, 43(4), 1993, pp. 384-384
THE USE OF PRAMIPEXOLE, A NOVEL DOPAMINE (DA) AGONIST, IN ADVANCED PARKINSONS-DISEASE
Authors: MOLHO ES FACTOR SA WEINER WJ SANCHEZRAMOS JR SINGER C SHULMAN L BROWN D SHELDON C
Citation: Es. Molho et al., THE USE OF PRAMIPEXOLE, A NOVEL DOPAMINE (DA) AGONIST, IN ADVANCED PARKINSONS-DISEASE, Neurology, 43(4), 1993, pp. 384-385
Risultati: 1-12 |